This study aims to delve deeper into the influence of KD on FGF21 expression and its responsiveness through the FGF21-KLB pathway, underscoring the pivotal role of FGF21-KLB signaling in mediating the KD’s beneficial effects on hepatic steatosis. This evidence concerns the gene FGF21 and fatty liver disease.